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ABSTRACT
Recently, several in vitro studies have shown that the golli–
myelin basic proteins regulate Ca
2+ homoeostasis in OPCs
(oligodendrocyte precursor cells) and immature OLs
(oligodendrocytes), and that a number of the functions
of these cells are affected by cellular levels of the golli
proteins. To determine the influence of golli in vivo on OL
development and myelination, a transgenic mouse was
generated in which the golli isoform J37 was overexpressed
specifically within OLs and OPCs. The mouse, called JOE
(J37-overexpressing), is severely hypomyelinated between
birth and postnatal day 50. During this time, it exhibits
severe intention tremors that gradually abate at later ages.
After postnatal day 50, ultrastructural studies and
Northern and Western blot analyses indicate that myelin
accumulates in the brain, but never reaches normal levels.
Several factors appear to underlie the extensive hypomye-
lination. In vitro and in vivo experiments indicate that golli
overexpression causes a significant delay in OL maturation,
with accumulation of significantly greater numbers of pre-
myelinating OLs that fail to myelinate axons during the
normal myelinating period. Immunohistochemical studies
with cell death and myelin markers indicate that JOE OLs
undergo a heightened and extended period of cell death
and are unable to effectively myelinate until 2 months
after birth. The results indicate that increased levels of golli
in OPC/OLs delays myelination, causing significant cell
death of OLs particularly in white matter tracts. The results
provide in vivo evidence for a significant role of the golli
proteins in the regulation of maturation of OLs and normal
myelination.
Key words: cell death, dysmyelination, golli protein,
myelination, oligodendrocyte development.
INTRODUCTION
The golli–MBPs (myelin basic proteins) are products of the
MBP gene (Campagnoni et al., 1993) and their functions have
only recently been determined. Early in vivo studies showed
that golli is expressed in some neuronal populations when the
cells are extending neurites and migrating (Landry et al.,
1996, 1997; Pribyl et al., 1993). In vitro studies have
suggested that overexpression of golli proteins in neuronal
and glial cell lines induced enhanced process extension and
sheet formation (Reyes and Campagnoni, 2002). More recent
work has shown that OL (oligodendrocyte) process extension
1To whom correspondence should be addressed (email acampagnoni@mednet.ucla.edu).
Abbreviations: BDNF, brain-derived neurotrophic factor; CC, corpus callosum; ClCsp3, cleaved caspase 3; CNP, 29,39-cyclic nucleotide phosphodiesterase; DIV, days in vitro;
FGFR, fibroblast growth factor receptor; GFAP, glial fibrillary acidic protein; GFP, green fluorescent protein; hemi, hemizygous; JOE, J37-overexpressing; MBP, myelin basic
protein; MyAP, myelinated axon profile; OL, oligodendrocyte; OPC, oligodendrocyte precursor cell; P, postnatal day; PDGFRa, platelet-derived growth factor receptor a; PLP,
proteolipid protein; TBS-T, Tris-buffered saline with Tween 20; WT, wild-type.
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asnneuro.org / Volume 1 (4) / art:e00017 213and retraction, and even migration, is due to the modulatory
effect of golli on Ca
2+ levels in the cells (Paez et al., 2007).
Studies in T-cell lines and in vivo models indicate that the
golli proteins also modulate Ca
2+ levels in cells in the immune
system (Feng et al., 2000, 2006). In vitro data indicate that
the golli proteins modulate Ca
2+ influx through store-
operated Ca
2+ channels and voltage-gated Ca
2+ channels in
OPCs (oligodendrocyte precursor cells). This modulation plays
an important role in OL process extension and retraction,
migration, proliferation and cell death (Reyes and
Campagnoni, 2002; Jacobs et al., 2005; Paez et al., 2007,
2009a, 2009b).
The purpose of the present study was to examine the effect
of golli overexpression in OLs in vivo, in a model in which a
golli isoform, J37, was specifically targeted to these cells. Thus
the phenotype of the JOE (J37-overexpressing) mouse would
represent a direct effect of golli on OLs. Such studies are
needed to validate in vitro findings, as well as to document
any effects of golli overexpression on OL development,
proliferation, survival or myelination. Towards that end, we
generated the JOE transgenic mouse in which the J37 golli
isoform is under the control of the classic MBP promoter. The
results of the in vivo analysis of this mouse have revealed a
profound effect of golli levels on OL development, survival
and myelination.
MATERIALS AND METHODS
Animal experimentation
All animals used in the present study were housed at the
UCLA School of Medicine Vivarium, and procedures were
approved by UCLA’s Animal Care and Use Committee and
conducted in accordance with the guidelines in ‘Guide for the
Care and Use of Laboratory Animals’ from the National
Institutes of Health.
Generation of the JOE construct and transgenic
mouse
The transgene for the JOE mouse was prepared using the 1.9
kb ‘classic’ MBP promoter plasmid (pMG2), a gift from Dr
Robert Lazzarini (Gow et al., 1992). The pMG2 plasmid
contains 1.9 kb of sequence upstream of the classic MBP
translation initiation site in exon 5B of the gene and a two-
exon piece of the b-globin gene to provide a splice site and
polyadenylation signal. In a unique EcoRI site in exon 3 of the
b-globin gene, we inserted the full-length cDNA for the J37
golli isoform in which the initiation ATG codon for golli–MBP
was retained as shown in Figure 1. Since the 59-portion of
the golli J37 cDNA contains the translation initiation site of
classic MBPs, the initiator methionine was mutated to a
leucine residue (using the Clontech site-directed mutagenesis
system) to assure that no classic MBPs arose from this
construct. The transgenic founders were produced by the
UCLA Transgenic Core Facility using the NotI fragment
injected into pronuclei of fertilized oocytes and transferred
to the oviducts of pseudopregnant mice. The background of
the transgenic founders (F1) was 50% Balb/cByJ, 37–50%
C57BL/6 and 0–13% C3H/He and they have been maintained
on this background.
Genotyping
To identify the transgenic founders, genomic tail DNA was
isolated and 4 mg was digested with EcoRI and analysed by
Southern blotting (Sambrook et al., 1989). Southern blots
were probed with a 1.8 kb EcoRI fragment of genomic DNA
that contains 88 bp of golli exon 3. This 88 bp of exon 3 in
the probe recognizes a 2.6 kb J37-containing EcoRI fragment
of the transgene and the entire 1.8 kb fragment hybridizes to
its counterpart in the native MBP gene. This normalization of
transgene to native gene allowed us to distinguish homo-
from hemi-zygous animals. We used PCR to distinguish
transgenic from WT (wild-type) animals before they could be
distinguished by the shaking phenotype, using a Denville Taq
Polymers kit and the following conditions: 4 min at 94˚C, and
35 rounds of 1 min at 94˚C, 1 min at 65˚C and 1 min at 72˚C,
followed by 7 min at 72˚C. The WT primer pair was: (59WT)
59-TGTTGGCAACTTTGGATGTGT-39 and (39WT) 59-TCAGCCAAGCC-
TTACCTTACT-39 which gave a band at 200 bp. The transgenic
primer pair was: (59J37) 59-CTTTCAGGGCAATAATGATACAA-39and
Figure 1 Generation of the JOE mouse
(A) The construct was prepared using the 1.9 kb ‘classic’ MBP promoter
plasmid (pMG2; Gow et al., 1992). This promoter element contains a 1.9 kb
sequence upstream of the classic MBP translation initiation site in exon 5B of
the gene and two exon pieces of the b-globin gene to provide a splicing
event. J37 cDNA was cloned into exon 3 of the b-globin gene. Since the 59-
portion of J37 cDNA contains the translation initiation site of classic MBPs,
the initiator methionine was mutated to a leucine residue to ensure that no
classic MBPs arose from this construct. (B) Western blot of samples from
three JOE transgenic lines, ‘B’, ‘D’ and ‘A’, at P24 probed with an antibody
against classic MBP. J37 contains 133 amino acids of golli-specific peptide
linked to classic MBP peptides 1–102 and 155–168. Our MBP antibody raised
against amino acids 12114 of bovine MBP recognizes J37 as well as classic
MBPs.
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product at 700 bp. The blots were analysed using a
PhosphorImager (GE Healthcare).
Analysis of the JOE transgenic mouse
Analysis of mRNA expression
At each developmental time point, RNA was isolated from
mouse brains using the TRIzolH method of Invitrogen. Each
time point on the subsequent Northern blot analysis
represents 10 mg of total RNA probed first with a 535 bp
cDNA for the coding sequence of mouse 14 kDa MBP (pP535)
and then stripped and probed with a mixture of a mouse
cDNA for the coding sequence of PLP (proteolipid protein)
(BAS1013) and cyclophilin (gift from Dr G. Sutcliffe, The
Scripps Research Institute, La Jolla, CA, U.S.A.). At each
probing, the blot was analysed using a PhosphorImager.
Loading errors were corrected by normalizing the values for
MBP or PLP time points to those for cyclophilin (P1B15).
Western blot analysis
Protein was precipitated from the organic phase of the
TRIzolH RNA extraction with propan-2-ol according to the
manufacturer’s instructions. The final protein pellet was
dissolved at room temperature (20˚C) in 8 M urea, 125 mM
Tris/HCl (pH 6.8), 4% (w/v) SDS and 3% (w/v) DTT
(dithiothreitol). The blot shown in Figure 3 represents 1 mg
of brain protein loaded on to an SDS/15% polyacrylamide gel
and run at 50 V until a Bromophenol Blue marker reached the
bottom of the gel. The proteins were transferred on to an
Immobilon P membrane which was blocked for 30 min in 5%
BSA (USB 10857 heat-shock fraction) and 0.02% NaN3 in
TBS-T (Tris-buffered saline with 0.1% Tween 20) then
incubated with shaking overnight at 4˚C with a rabbit
polyclonal antibody raised against amino acids 1–115 of
bovine MBP. The next day, it was washed three times for 5
min with TBS-T, blocked for 30 min in 5% (w/v) non-fat
powdered milk in TBS-T and incubated with shaking for 1 h in
the same buffer now containing HRP (horseradish perox-
idase)-linked anti-rabbit IgG (GE Healthcare), and washed six
times with TBS-T. The blot was developed with the ECLH
(enhanced chemiluminescence) system (GE Healthcare).
Tissue preparation
Tissue was collected from JOE and littermate WT animals, as
well as from offspring of JOE mice mated with PLP–GFP
(green fluorescent protein) mice (Mallon et al., 2002) that we
have designated JOE
plp/gfp. Postnatal animals were prepared
and analysed for immunohistochemical and ultrastructural
analyses. At each developmental time point, animals were
anaesthetized with sodium pentobarbital and given intracar-
diac perfusions with 4% (w/v) buffered paraformaldehyde.
The brains were removed from the skull and post-fixed in the
same fixative overnight at 4˚C. After post-fixation, brains
were embedded in 4% agarose and sectioned coronally at 40
mm on a vibratome (Leica VT1000S). For ultrastructural
analysis, animals were perfused with 2% (w/v) glutaralde-
hyde/2% (w/v) paraformaldehyde in a sodium cacodylate
buffer. Specific brain regions were then post-fixed with 1%
OsO4, dehydrated and embedded in Epon. Ultra-thin sections
were stained with uranyl acetate and lead citrate and
examined with a JEOL JEM-100CX electron microscope.
Immunohistochemistry and antibodies
Free-floating vibratome sections were incubated in a blocking
solution (2% normal goat serum and 0.1% Triton X-100 in
PBS) for 1 h at room temperature and then incubated with
the primary antibody overnight at 4˚C. Sections were then
rinsed in PBS and incubated with the Alexa FluorH 594 (red)
or Alexa FluorH 498 (green) -conjugated secondary antibody
(Invitrogen) for 2 h at room temperature followed by a
counterstain with the nuclear dye bisbenzimide (Hoechst
33342; Invitrogen). After washing, the sections were mounted
on to Superfrost Plus slides (Fisher) using coverslips and
mounting medium (Aquamount; VWR). For antibodies
requiring antigen retrieval [ClCsp3 (cleaved caspase 3) and
histone H3], sections were incubated in sodium citrate buffer
for 20 min at 95˚C, cooled at room temperature for 20 min,
washed three times in PBS and then processed as described
above. In those experiments where sections were stained with
3,3-diaminobenzidine (Roche), free-floating sections were
incubated in a solution containing 0.3% H2O2 and 10%
methanol for 10 min, rinsed and then incubated with the
primary antibody at 4˚C overnight. After washing, the
sections were incubated with a biotinylated secondary
antibody for 1 h at room temperature and the secondary
antibody was visualized using the avidin–biotin–peroxidase
method (Vectastain Elite ABC) as recommended by the
manufacturer (Vector Laboratories).
The primary antibodies used in the present study were
against: CC1 (diluted 1:500; Calbiochem/EMD Biosciences),
ClCsp3 (diluted 1:250; Cell Signaling Technology), CNP (29,39-
cyclic nucleotide phosphodiesterase) (diluted 1:500;
Neomarkers), polyclonal antibody for golli (diluted 1:1000;
XX70), 01 (diluted 1:20), 04 (diluted 1:40), PLP/DM20 (diluted
1:400; clone AA3; gift from Steven Pfeiffer, University of
Connecticut Health Science Center, Farmington, CT, U.S.A.)
and PDGFRa (platelet-derived growth factor receptor a)
(diluted 1:200; BD Biosciences). Antibodies against GFAP (glial
fibrillary acidic protein) (diluted 1:200), phospho-histone H3
(diluted 1:1000), NeuN (diluted 1:1000), NG2 (diluted 1:300),
Olig2 (1:800), Sox9 (diluted 1:500) were all purchased from
Chemicon/Millipore.
Cell preparation and immunocytochemistry
Primary OL cultures were isolated from cortices of individual
JOE and control littermates between P (postnatal day) 0 and
P3. Cells from each pup were cultured separately while the
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215mouse was genotyped. Genotyping was performed on tail
DNA using standard PCR protocols from our laboratory (Xie et
al., 2002) optimized for the current primers. After genotyp-
ing, JOE and WT brain cultures were pooled separately and
continued to be grown as described previously (Amur-
Umarjee et al., 1993; Givogri et al., 2001). Immunocyto-
chemistry experiments were performed as described by Reyes
and Campagnoni (2002).
Microscopy and statistical analyses
Images were collected with a Leica DM RXA microscope using
conventional transmission microscopy or epifluorescence.
Images were captured with a Spot CCD (charge-coupled
device) camera (Diagnostic Instruments) and assembled into
Figures using Adobe Photoshop CS software. Estimates of the
density of labelled cells were determined by examining
coronal cortical sections at 4006 and counting the number
of labelled cells within comparable regions of the CC (corpus
callosum) (four areas per hemisphere) and cortex (three areas,
upper cortex and three areas, lower cortex per hemisphere).
Depending upon the age, four to six sections spanning the
rostral to caudal extent of the CC were analysed from a
minimum of three animals per age and genotype. Electron
microscopy was performed using a JEOL JEM-100CX electron
microscope. Measurements of axonal and fibre diameter were
made from images taken at 140006 of myelinated axon
profiles in the CC of JOE and WT mice at P28 and P60. G-
ratios were calculated by dividing the axonal diameter by
fibre diameter. For all measurements, the statistical signifi-
cance of differences of the S.E.M. was determined using a
one-tailed Student’s t test. The results are expressed as
means¡S.E.M.
RESULTS
Mice overexpressing golli exhibit neurological
abnormalities
To examine the effect of golli on OL development, several
lines of transgenic mice were generated in which the J37 golli
isoform was overexpressed in OLs using a classic MBP OL-
specific promoter (Gow et al., 1992). Figure 1 shows a
Western blot of three JOE lines (B, D and E) at P24. All three
JOE lines exhibited clinical behavioural abnormalities begin-
ning at ,P14 that persisted until ,P60, after which they
were less evident. We chose to examine line B in more detail
and refer to this line as JOE in the present study. The
homozygous JOE mice were embryonic lethal, but the
hemizygous (hemi) mice were born with no obvious
behavioural differences from their control littermates.
However, by P14, the hemi JOE mice began to display an
intention tremor (see Movie 1 and Supplementary Figure S1
at http://www.asnneuro.org/an/001/an001e017add.htm) that
is localized to the tail. By P30, the tremor was very pro-
nounced and involved the entire body. At this age, the JOE
mice occasionally exhibited a seizure. Between P35 and P60,
the severity of the tremors declined. Behaviourally, adult
hemi mice (.P60) appeared normal, but they continued to
tremble when placed under proprioceptive load. JOE mice had
slightly smaller body weights compared with littermate
controls at P28 (i.e. 87–89% of controls) and this difference
persisted into adulthood.
JOE mice undergo a substantial delay in brain
myelination
The nature of the neurological phenotype and the targeting
of golli overexpression to the OLs suggested a problem with
myelination. The extent of myelination in JOE brains was
examined by immunohistochemistry with an antibody against
PLP. At P28, fewer PLP
+ fibres and cell bodies were detected
in the JOE cerebral cortex than in WTs, indicating substantial
hypomyelination (Figures 2A and 2B). This lack of myelination
occurred throughout the brain including the cerebellum (data
not shown), which may explain the severe intention tremors
observed at this age. By P40, PLP immunostaining increased
in the JOE cortex, but not nearly to the extent that might
have been predicted by the loss of the tremors (Figures 2C
and 2D). The basal intention tremors practically disappeared
by this age, but the extent of myelination remained relatively
low. At later ages, myelin staining in the JOE mice became
close to normal, but many fibre tracts such as the cerebellar
peduncles and pyramidal tracts in the cerebellum remained
hypomyelinated. Histochemical analyses of myelin with the
Weil stain supported these conclusions with a lack of staining
in JOE brains compared with controls (data not shown). The
density and organization of the myelinated fibres were also
affected in the JOE brains. At higher magnification, labelled
fibres were clearly sparser and more disorganized in
comparison with the dense and radial organization of the
fibres in controls (see insets in Figure 2). Also present in the
JOE cortex were foci of isolated myelinated segments (see
arrows in Figure 2C) that were not observed in the WT. Note
that these are not pre-myelinating OLs, described in detail
below, at this age.
Golli overexpression alters levels of MBP and
PLP/DM20 myelin mRNA and proteins
To assure that golli overexpression was occurring in the brain,
and to determine the expression pattern of the classic MBPs,
Northern and Western blot analyses were performed on JOE
and WT brain mRNAs and proteins. A Western blot probed
with anti-MBP is shown in Figure 3. Overexpression of golli
J37 could be detected as early as P1.5 (the earliest age
examined) and persisted for as long as 13 months (the latest
age examined). With development the classic MBPs increased
in amounts as myelin deposition began to occur. Figure 4
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blot of total RNA, probed, stripped and reprobed for MBP, PLP
and cyclophilin mRNAs. The same blot was probed with an
18S rRNA probe for quantitative measurements to assure
equivalence of loading in the lanes (data not shown). The
data indicate that the timing of expression of the classic
MBP and PLP/DM20 transcripts appear to be unaffected by
overexpression of golli J37. However, the levels of the mRNAs
appear to be 2.5–4-fold lower in the JOE than in WT before
P50. Western blot data indicated that significant accumula-
tion of classic MBPs did not begin until P35–P50, a timing
that corresponded to the first histological signs of myelina-
tion in the JOE brains.
Figure 2 Decreased PLP expression in JOE brains
Coronal sections from JOE and WT mice at P28 (A and B) and P40 (C and D) were immunostained with anti-PLP. In (A), decreased PLP
staining was quite evident in the P28 JOE brain in comparison with the WT (B). Particularly affected was the amount of staining in
the cortical OLs with little label in the cell bodies or processes. By P40, PLP staining in the JOE brain (C) increased, but did not reach
the level of staining seen in WT sections (D). Isolated foci of PLP myelinated segments were detected in the outer cortical layers (see
arrows in C). Insets in (A–D) illustrate the reduced staining in OL processes as well as the extent of disorganization of the fibres in
the JOE brains compared with controls. Magnification 625, insets 650.
Figure 3 Delayed expression of the classic MBP proteins
Western blot of classic MBPs and golli in JOE mice at P24, P35 and P50
showing overexpression of golli at all ages. Classic MBP levels were very low
below P50 and began to increase in JOE mice at 50 days and beyond,
consistent with a delay in myelination. Even so, classic MBP levels were
significantly lower than the levels in WT mice.
Figure 4 Reduced levels of PLP/DM20 and classic MBP mRNAs
Phosphorimages of the same Northern blot probed for PLP/DM20, classic MBP
and cyclophilin mRNAs. Lower levels of PLP/DM20 and MBP mRNAs were
observed in JOE brains at all ages. However, the developmental timing of
mRNA expression remained the same between the genotypes.
Overexpression of golli J37 isoform in oligodendrocytes
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217Ultrastructural analysis suggests dysmyelination
not demyelination occurs in the JOE brain
We examined the quality of the myelin formed in the JOE
CNS (central nervous system). Ultrastructural changes of
MyAPs (myelinated axon profiles) were studied in the CC at
P28 and P60 by electron microscopy. At both ages, the
majority of the axonal profiles in the JOE CC were not
myelinated, but the myelin that formed appeared to have
regular periodicity and structure, including the presence of
the mesaxon. For example, at P28, very few MyAPs were
observed in the CC of the JOE mouse compared with controls
(Figures 5A and 5B). Of those axons that were myelinated,
each had fewer wraps of myelin membrane than myelinated
WT axons, as indicated by their G-ratio (axonal diameter
divided by fibre diameter; larger numbers reflecting reduced
myelin thickness). At P28, the average myelin thickness in
controls (G-ratio50.76¡0.01) was significantly greater
compared with JOE (G-ratio50.86¡0.01; P,0.01). At P60,
the number of MyAPs increased in the JOE CC (Figure 5C), but
the average myelin thickness remained unchanged and lower
than controls (Figure 5D). The gradual appearance of
myelinated axons over time along with the absence of
myelin debris in extracellular spaces (data not shown)
suggests that active demyelination was not occurring.
Rather, our data are consistent with the conclusion that
JOE brains undergo dysmyelination; and, although they
began to recover at around 2 months of age, they never
reached the extent of myelination observed in WT animals.
Reduced number of OLs detected in JOE brains
The results from the electron microscopy and biochemical
studies suggested that fewer OLs were present in the JOE
brain. To test this hypothesis, we crossed the JOE mice to mice
expressing GFP driven by the PLP promoter (PLP–GFP; Mallon
et al., 2002). Since the JOE mice were hemizygous, each litter
produced JOE PLP–GFP (JOE
plp/gfp) and control mice that
expressed GFP in OLs. As shown in Figure 6 and Table 1, the
number of GFP-labelled cells at P14 was significantly greater
in the JOE
plp/gfp cortices in comparison with their littermate
controls (Figures 6A and 6B). By P28, the number of JOE
plp/gfp
GFP
+ cells was reduced to less than 50% of the control
(Figures 6C and 6D). At P60, the numbers of GFP
+ cells
increased in both genotypes, but the number of labelled cells
in the JOE
plp/gfp cortices remained significantly lower than in
the controls (Figures 6E and 6F).
Extended period of cell death in the JOE mouse
We examined the cause/dynamics for the reduced number of
OLs by performing immunohistochemical studies to deter-
mine the number of apoptotic and proliferating cells in the
cerebral cortex and CC at several postnatal ages. Specifically,
coronal sections of JOE
plp/gfp and control brains were
examined at P14, P28 and P60 and stained for either
ClCsp3 (a marker of cells undergoing apoptotic cell death) or
phospho-histone H3 (a marker of phosphorylated histone H3
proteins present during cell proliferation). Moreover, to
Figure 5 Severe hypomyelination is evident in the JOE CC
Electron micrographs reveal extensive hypomyelination in the JOE CC at P28 (A and B). The number of myelinated axon profiles
increased by P60 (C and D). At both ages, the JOE axons that were myelinated had significantly thinner myelin than that found in the
WT CC. Magnification 614000.
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+ cells being counted were OLs, we
performed our analysis on tissue sections from the JOE
plp/gfp
mice; only counting cells that were labelled for both markers,
i.e. GFP and ClCsp3
+ or H3 (see Figures 7A–7A99 and 7B–7B99).
We also confirmed OL identity by examining the morphology
of the ClCsp3
+ cells. Bipolar cells (found primarily in the CC)
and multi-branched cells (resembling pre-myelinating OLs) in
the cortex were included in the calculations. On alternate
sections, histone H3
+ cells were stained and counted in the
cortex, CC and underlying subventricular zone.
The density of ClCsp3
+ cells in the CC and cortex of
JOE
plp/gfp and control mice are shown in Figure 7(C) at P14,
P28 and P60. In the cortex of both JOE
plp/gfp and control
mice, the density of ClCsp3
+ cells was highest at P14 and
declined with age. There was no significant difference
between the cortices of the two genotypes over the time
frame of the study. In contrast, there was a significant
difference in the developmental pattern of ClCsp3
+ OLs in the
CC of JOE
plp/gfp compared with the CC of control mice. At all
ages examined, the density of ClCsp3
+ cells was significantly
higher (P,0.05) in the JOE
plp/gfp CC than in the control CC.
Interestingly, between P14 and P28, the number of ClCsp3
+
OLs in the JOE
plp/gfp CC actually increased substantially
(165%), rather than declined, but then declined precipitously
between P28 and P60. The decline in ClCsp3
+ OLs in the
control CC paralleled the trend observed in the cortex of both
the JOE
plp/gfp and control mice. We did not detect increased
neuronal cell death in the JOE
plp/gfp cortex during this
developmental period.
On adjacent cortical sections, the tissue was processed for
the proliferation marker, histone H3 and the density of GFP
+/
histone H3
+ double-labelled cells in the subventricular zone,
CC and overlying cortex was quantified. In each of these
areas, we found no significant difference in the number of
Figure 6 Fewer GFP
+ OLs detected in the JOE cortex
Coronal cortical sections from JOE6PLP–GFP (JOE
plp/gfp) hemi and WT mice at P14 (A and B), P28 (C and D) and P60 (E and F). The
number of GFP-labelled OLs in the JOE
plp/gfp mice were reduced and localized in disorganized clusters in comparison with the more
radially aligned OLs labelled in the WT mice (control). Magnification 650 (A–D), 6100 (E and F).
Table 1 Mean¡S.E.M. number of EGFP (enhanced GFP)-labelled cells in
the cortices of JOE
plp/gfp and control mice at P14, P28 and P60
Using a Student’s t test, differences at each age were found to be significant
at P,0.05.
Age JOE
plp/gfp Control P value
P14 188¡7.0 157¡1.13 0.049
P28 143¡13.4 335¡37.8 0.040
P60 302¡36.4 492¡45.4 0.030
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219proliferating cells between the genotypes over the period
examined (P14 and P60) (Figure 7D). These results indicate
that, whereas OL proliferation is relatively unaffected, OL cell
death is higher in JOE brains than in WT brains.
Highly branched multi-processed pre-
myelinating OLs are quite prominent in JOE
brains
One of the most striking histological features of JOE brains is
the presence of numerous highly branched multi-processed
cells that label with the golli-specific antibody. These cells are
prominent throughout the CNS and are present in the JOE
brain throughout the developmental period examined: P4–
P120. Within the cortex, these cells are located primarily in
layers I–III where they encompass large areas of non-
overlapping neuropil (see Figure 8A and arrows in
Figure 8C). This type of cell is not evident with golli
immunostaining of the WT (Figures 8B and 8D). However,
the distribution and morphological characteristics of these
cells suggest that they are pre-myelinating OLs. Pre-
myelinating (immature) OLs have been well characterized in
vitro (Gard and Pfeiffer, 1990; Hardy and Reynolds, 1991;
Dubois-Dalcq and Armstrong, 1992; Miller, 1996; Nishiyama
et al., 1996), but less is known about their attributes in vivo.
Trapp et al. (1997) have shown that, in the rodent brain, pre-
myelinating OLs are likely to originate from NG2/PDGFRa
progenitors, but are themselves PDGFRa- and NG2-negative.
These authors did find a small but consistent subpopulation
of pre-myelinating OLs that were NG2-positive. To investigate
these presumed golli
+ pre-myelinating OLs in the JOE mouse,
coronal sections were double-labelled with antibodies for golli
(green) and OL markers O4, Sox9, Olig2, NG2 or PDGFRa (red).
As shown in Figure 8, at P14, golli
+ cells with pre-myelinating
Figure 7 Increased cell death in JOE
plp/gfp cortices
Coronal sections from JOE6PLP–GFP (JOE
plp/gfp) hemi (A–A99) and control (B–B99) mice immunostained for apoptotic marker ClCsp3
(red) at P28. Magnification 6200. The average density of ClCsp3
+ cells in the CC and cortex at P14, P28 and P60 is quantified in (C).
Within the CC, the number of ClCsp3
+ cells were significantly greater in the JOE
plp/gfp than in control sections (P,0.05) at each
developmental time point. In the cortex, the number of labelled cells was not significantly different between the genotypes. (D) The
average density of proliferating cells (histone H3
+) for the control and JOE mice did not differ between genotypes.
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labelled for the early OL markers O4 (Figure 8E), Sox9
(Figure 8F) and Olig2 (Figure 8G). Although an occasional
golli
+ cell stained with anti-NG2 (data not shown), the golli
+
pre-myelinating OLs were essentially negative for the
progenitor markers NG2 (Figure 8H) and PDGFRa
(Figure 8I). In addition, these cells did not express antigens
for neuronal (NeuN, TUJ1) or astrocytic (GFAP) markers (data
not shown).
One of the most consistent markers for these cells has been
the co-localization of golli (red) with GFP (green) expression
in the JOE
plp/gfp mouse (see Figure 8J). Since in these mice,
GFP is under the control of the PLP/DM20 promoter, our data
are consistent with Trapp et al. (1997) who found PLP/DM20
expression in pre-myelinating OLs. Interestingly, although the
PLP/DM20 promoter is active in these cells, they labelled only
lightly with anti-PLP. In the present study, co-localization of
golli in these cells with other early OL markers 04, Sox9 and
Olig2 (Figures 8E, 8F and 8G respectively) is consistent with
their categorization as pre-myelinating/immature OLs.
One of the primary differences between the brains of JOE
and WT mice is the number and persistence of the pre-
myelinating OLs. In the WT brain, the number of pre-
myelinating OLs peaks during the first 1–2 weeks after birth,
and very few are detectable after P30 which is consistent
with the findings of Trapp et al. (1997). In the JOE mice, the
number of pre-myelinating OLs also peaks during the first 2
weeks after birth. However, there is nearly twice the number
of these cells in the JOE animals than in the WT mice. In
addition, a subpopulation of pre-myelinating cells persists
into adulthood in the JOE mice. Note, that the PLP staining in
the outer JOE cortices shown in Figure 2(C) are not pre-
myelinating OLs, but rather foci of anti-PLP-labelled fibre/
process segments.
Since myelination is apparently delayed in the JOE mice, we
examined primary cultures of JOE OLs to determine whether
this delay is indicative of an intrinsic property of JOE OLs.
Specifically, cortical OLs from P0–P3 mice were cultured and
examined at 14 DIV (days in vitro) and at 28 DIV to assess the
morphology of the OLs as well as their capacity to elaborate
membrane sheets. At 14 DIV, a comparison of 04
+ cells
(Figures 9A and 9B) showed the presence of multi-polar cells
in both WT and JOE cultures. However, upon closer
inspection, these cells in the JOE cultures tended to contain
more processes that were highly branched and similar to the
pre-myelinating cells observed in vivo. This was even more
apparent in 14 DIV cultures immunostained for golli. In the
WT cultures, many of the golli
+ OLs were bipolar (Figure 9C).
In contrast, most of the golli
+ cells in the corresponding JOE
cultures were very highly branched and multipolar
(Figure 9D). The cultures were also examined at 28 DIV when
sheet formation is well advanced in the WT cultures. As
shown in Figure 9(E), WT cells immunostained for the mature
OL surface marker, 01, displayed large expansive myelin-like
sheets. In the JOE cultures, 01
+ cells were highly ramified with
extensive and highly branched processes (Figure 9F). These
results indicate that JOE OLs remained largely in an immature
state of differentiation and that large numbers of pre-
myelinating OLs seem to predominate in JOE brains.
Figure 8 Immunohistochemical staining of highly branched golli-
expressing cells in the JOE brain
Using immunoperoxidase staining with a golli-specific antibody (A–D), these
cells were detected throughout the brain (A). Within the cortex (C) [a higher
magnification of the outlined area in (A)], these cells were observed to be most
prevalent in cortical layers I–III (for examples, see arrows) and were clearly
absent from the WT (B and D). In sections stained with fluorescently labelled
antibodies, these golli
+ cells (green)co-localized withthe early OLmarkers:anti-
O4 (E), anti-Sox9 (F) and anti-Olig2 (G), but were negative for the progenitor
markers anti-NG2(H) and anti-PDGFRa (I)[ E–I, developmentalmarkers (red)].(J)
the PLP/DM20 promoter is active in these cells as evident by the co-localization
of golli (red) with GFP in JOE
plp/gfp sections. Images taken at P28 (A–D) and P14
(E–J). Magnification 625 (A and B), 650 (C and D), 6400 (E–J).
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221Differential effect of golli overexpression in OL
development
In examining the development of OLs in the JOE cortex, there
appear to be significant regional differences in the stage of
morphological development. In Figure 10, representative OLs
at P14 immunolabelled with anti-golli antibodies are shown
from the outer cortical layer (Figure 10A), middle cortex
(Figure 10B) and the CC (Figure 10C). The morphologies of
the OLs are typical of this stage of cortical development and
include pre-myelinating OLs (Figure 10A), more mature OLs
with radially aligned processes (Figure 10B) and interfasci-
cular OLs in the CC (Figure 10C). In addition to the high
numbers of pre-myelinating OLs, significantly less PLP
immunoreactivity was evident in the OL processes in all
cortical regions. In the immature pre-myelinating OLs, PLP
immunostaining was either non-detectable or barely detect-
able as faint perinuclear staining (Figures 10A9 and 10A99). In
later-stage OLs, it is necessary for the OL to transport PLP to
the processes for myelination to occur. As shown in
Figures 10(B9) and 10(B99), these OLs are immunoreactive
for PLP, but the label is primarily restricted to the cell body,
with only faint label in the processes. In corpus callosal OLs
(Figures 10C–10C99), PLP immunoreactivity infiltrated much
further into the processes than in OLs from the mid-cortical
region, although OLs in the CC (Figures 10C9 and 10C99) did
exhibit some accumulation of PLP immunoreactivity in the
cell body. This may explain why the axons in the CC are more
heavily myelinated relative to the axons in the upper cortical
zones.
DISCUSSION
In the present paper, we report the in vivo consequence of
altered Ca
2+ homoeostasis in OPCs/OLs owing to golli
overexpression in those cells. Golli overexpression resulted
in a delay in myelination of ,6 weeks and a striking
neurological phenotype characterized by tremors that
increased in severity and body involvement from P14 to
P35 and by occasional seizures. Our analysis of the JOE CNS
indicates that the underlying cause for the tremors is
apparently due to a significant delay in the onset and extent
of myelination (see also Martin et al., 2007). Although the
entire CNS is affected, the focus of analysis in the present
study has been on the perturbations observed in the cerebral
cortex and CC.
Use of the classic MBP promoter permitted us to target
overexpression of the golli protein specifically to OLs and
their precursors. Although the classic MBPs are generally
considered to be expressed in mature OLs, there are numerous
reports of the promoter being active in cells earlier in the OL
lineage. The classic MBP mRNAs, if not the proteins, have
been reported to be expressed embryonically as well as in
early postnatal animals (Mathison et al., 1993; Nakajima et
al., 1993; Hajihosseini et al., 1996; Peyron et al., 1997; Zecevic ´
et al., 1998; Campagnoni and Skoff, 2001; Tosic ´ et al., 2002;
Jalabi et al., 2005). In the present study, we have confirmed
that the MBP promoter–golli transgene is active perinatally in
the brain, long before active myelination. Thus, in addition to
mature OLs, the activity of the classic MBP promoter
appeared to drive expression of golli J37 in OPCs, later-stage
OL progenitors and immature OLs.
Other mouse models have been generated by transgenes
driven by the classic MBP promoter. These have included
oncogenes (Hayes et al., 1992), MHC molecules (Turnley et al.,
1991), TNFa (tumour necrosis factor a) (Taupin et al., 1997),
c-myc (Orian et al., 1997, 2001), FGFR (fibroblast growth
factor receptor) (Harari et al., 1997), BDNF (brain-derived
neurotrophic factor) (Forsberg-Nilsson et al., 2003) and
reporter genes such as lacZ (Gow et al., 1992; Miskimins et
al., 1992; Vanderluit et al., 2000). Surprisingly few of these
transgenics have exhibited serious overt neurological pheno-
types or major myelination disturbances, suggesting that
overexpression of any gene is not damaging to the OL. The
overexpression of the c-myc (Orian et al., 1997) and MHC
(‘wonky’ mouse) genes in OLs has been reported to cause a
Figure 9 Enhanced process extension and decreased myelin-like sheet
formation in JOE OLs in vitro
Mixed cortical cultures from WT (A, C and E) and JOE (B, D and F) cultured
from P0–P3 mice and imaged at 14 and 28 DIV. Fluorescent images of 14 DIV
OLs immunostained with anti-O4 antibody (A and B) and golli (C and D)
illustrate the more highly branched processes in the JOE cultures. (E and F)A t
28 DIV, O1
+ OLs in the JOE cultures were multi-branched and showed a lack
of myelin-like sheets that were evident in the WT. Magnification 6400.
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MHC transgenic mouse line, disturbance of locomotor activity
from P11 to P14 was noted, followed by tonic seizures
leading to premature death by P15–P22. Another transgenic
mouse, called 2-50, has been generated through the
expression of the proto-oncogene, myc, under the control
of the classic MBP promoter (Orian et al., 1997, 2001). This
mouse exhibits tremors transiently from P15 to P25 and
appears to undergo delayed myelination because of transient
expression of the transgene in OPCs during embryonic
development. Myelination and myelin apparently become
completely normal with further postnatal maturation. This
mouse does not express the transgene beyond very early
postnatal development, unlike the JOE mice, which express
the transgene as early as P1.5 (earliest age examined) and
continues to at least 13.5 months (latest age examined).
Other models, such as transgenic mice expressing BDNF or
FGFR under control of the classic MBP promoter appear to
have rather subtle effects on myelin and do not exhibit any
neurological symptoms. The JOE mice are also unlike the
spontaneously occurring dysmyelinating mutants (e.g. shi,
shi
mld, jimpy) and the PLP-overexpressers. These animals
suffer from dysmyelination, which results in permanent
myelin deficits or premature death through seizures. The JOE
mice are hypomyelinated and exhibit neurological tremors
over a considerable and important period in the developing
brain, after which there appears to be significant recovery of
myelination.
It has become apparent that golli proteins are important in
OPC/OL process extension and retraction. For example, when
golli proteins are overexpressed in OL cell lines, they induce
the elaboration of processes and sheet-like structures (Reyes
and Campagnoni, 2002; Paez et al., 2007) that do not have
the composition of myelin. In transfected cells, golli co-
localizes with F-actin (filamentous actin) in the plasma
membrane along the extending processes and at the leading
tips (J.M. Feng and A.T. Campagnoni, unpublished data),
suggesting that golli may influence process motility. It is
likely that this results from the role that golli proteins play in
modulating Ca
2+ influx at the plasma membrane (Jacobs et
al., 2005; Paez et al., 2007, 2008, 2009a).
From what we know about the cellular localization of golli
and its influence on process formation in vitro, one might
predict that, in the presence of increased golli expression, OLs
in the JOE mouse would remain in a less mature state,
extending processes, but not differentiating further into
mature OLs. The results from the present study support this
hypothesis. Specifically, the data from our in vitro studies
show a clear reduction in the ability of purified JOE OLs to
produce myelin-like sheets in comparison with WT OLs in
Figure 10 Comparison of the PLP levels and transport in JOE OLs
Representative OLs from the outer (A) and inner (B) cortical layers and the CC (C) are shown in corresponding rows immunostained
for golli (green) and PLP (red). Pre-myelinating OLs are not stained with the PLP antibody (see arrows in A´´). However, OLs in the
inner cortical layers and CC are PLP-positive. The PLP immunoreactivity is localized primarily to the cell bodies. Process staining for
PLP is more extensive in CC OLs. Magnification 6400 (A–A´´ and B–B´´), 6200 (C–C´´).
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223culture. Instead, these JOE 01
+ cells were characterized by
highly ramified processes, but without extensive sheet
formation. These results with isolated OLs are different from
golli overexpression in cell lines. Isolated JOE OLs primarily
elaborate processes rather than sheets, revealing an inter-
esting difference in cell lines compared with isolated OLs.
Interestingly, impeded maturation of OLs in vivo was greater
in the outer cortical layers (I–III), than in the deeper cortical
regions and CC in the JOE compared with WT brains.
Pre-myelinating OLs are a transient population of cells that
extend elaborate processes over a significant area (80 mmi n
the cortex and 40 mm in the CC) and largely disappear after
P21 (Trapp et al., 1997). The surviving cells are thought to be
those that contact and ensheathe axons and differentiate
further into mature myelin-forming OLs. The greater numbers
of pre-myelinating cells in the JOE mouse, particularly
between P14 and P28, and their continued presence in the
adult suggest that overexpression of golli impedes and/or
delays the development of OLs.
Whereas the number of pre-myelinating OLs was greater in
the JOE brains, some OLs did differentiate into a more mature
phenotype, particularly those in the lower cortical layers (III–
VI). These OLs tended to have fewer processes than the pre-
myelinating OLs, and these processes had a more organized
and vertical appearance, suggesting that they were aligning
along side adjacent axons. However, results from our PLP
immunohistochemical studies and ultrastructural analysis
indicated that these cells were not able to myelinate nearby
axons. In the CC, many of the OLs had typical intrafascicular
morphology and were able to myelinate axons. However, the
amount of myelin (number of wraps per axon) was
significantly less than that produced in the WT.
In WT brains, pre-myelinating OLs in the upper cortical
layers did not stain for PLP very well, but the OLs in the lower
cortical layers and the CC did. The same pattern was roughly
true for the JOE mouse. However, the PLP
+ OLs in the lower
cortical layers that appeared to mature beyond the pre-
myelinating stage produced PLP, but the majority of the
protein remained in the cell body. In contrast, OL processes in
the JOE CC were stained more heavily for PLP. This difference
may explain why, in contrast with the cortex, myelination,
albeit reduced, occurred in the JOE CC. It is possible that
regional differences in rates of maturation of OLs or the
originating (embryonic) sources of the OLs in these areas of
the cortex and subcortical white matter (Kessaris et al., 2006)
account for these differences.
Our finding that OLs in the CC and cortex respond
differently to overexpression of golli J37 suggests that there
may be innate differences in sensitivity to increased golli
expression among various subpopulations of OLs. This
conclusion is consistent with increasing evidence in the
literature that OPCs and OLs are heterogeneous populations
of cells. Their heterogeneity has been documented with
respect to their temporal and spatial sites of developmental
origin (Kessaris et al., 2006; Ivanova et al., 2003; Noble et al.,
2003) as well as their genetic (reviewed by Nicolay et al.,
2007) and morphological phenotype (Del Rio-Hortega, 1928;
Weruaga-Prieto et al., 1996). Pre-myelinating OLs in the CC
have also been shown by Trapp et al. (1997) to have
significant morphological and structural differences than
those found in the cerebral cortex. This well-documented
heterogeneity among OL populations may underlie the
differences that we noted in the OPC/OL populations in the
layers of the cortex and subcortical white matter in the JOE
brain.
One consequence of golli overexpression in vivo appears to
be an inhibition or delay of myelination. This delay may be due
to the extensive cell death of OPC/OLs that we observed in the
JOE mouse during the first two postnatal months. This
increased cell death is likely to be a result of a perturbation
in Ca
2+ homoeostasis owing to increased production of golli.
Our previousworkshowedthatgollienhancesCa
2+uptakeinto
OLs and OPCs and this can lead directly to cell death (Jacobs
et al., 2005; Paez et al., 2009a). It is well-documented that
increased influx of Ca
2+ can be lethal in many cell types
includingOLs(Orrenius et al., 2003;Benjaminsand Nedelkoska,
1996; Smith and Hall, 1994). Thus these in vivo findings are
consistent with in vitro studies by Paez et al. (2009a), who
found an increase in apoptotic cell death in JOE OPCs cultured
under basal conditions. Moreover, when cultures of OPCs from
golli-knockout mice were treated with high levels of K
+
(inducing Ca
2+ influx), Paez et al. (2009a) found that they were
more resistant to apoptotic death than controls.
At a cellular level, early stages of OPC maturation may
actually be accelerated by overexpression of golli. For
example, we know that migration is increased in OLs both
in vivo and in vitro (Paez et al., 2009b). However, we believe
that golli has no role in the elaboration of myelin sheets and
may in fact inhibit that process. In JOE mice, increased golli
expression may enhance this inhibition and account for the
delay in further OL maturation. Eventually, other factor(s)
intervene and override the inhibition. This factor could
include, but is not limited to, lower expression of the MBP
promoter with development and/or the interaction with other
molecules.
One of the most interesting phenotypic characteristics of
the JOE mouse is its delayed recovery of near WT levels of
myelin and loss of neurological systems by ,60 days. In vitro,
increases in internal Ca
2+ have been shown to increase
proliferation of JOE OPCs in culture (Paez et al., 2009a). In the
JOE mouse, there was an ,20% increase in the number of
GFP
+ OLs in JOE
plp/gfp brains compared with controls at P28
and P60, but the results were not statistically significant. It is
possible that this small difference over time could result in a
‘rebound’ effect that eventually leads to the myelination
occurring at later ages. However, another interpretation is
that the small increase of histone H3
+ proliferating cells in
older animals (P28–P60) suggests that remyelination is
unlikely to be due to the production of newly generated
OPCs. Rather, the continued presence of pre-myelinating OLs
suggests a greater pool of immature OLs that could be
recruited in JOE animals that are able to differentiate and
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when the activity of the MBP promoter declines (after ,21–
28 days), reducing the intracellular levels of the golli J37
protein.
The lack of a difference in proliferating OLs between the
JOE and WT mice is surprising given the increase in
proliferation of JOE OPCs observed in vitro (Paez et al.,
2009a). However, although we did not detect an increase in
proliferating histone H3
+ cells between P14 and P60, we did
detect a greater number of GFP
+ OLs at P14 in the JOE
plp/gfp
cortices. One explanation for this difference may be that
increased proliferation occurred in the JOE
plp/gfp mice before
P14. Furthermore, increased rates of OPC migration in the
JOE
plp/gfp may also explain the presence of a greater number
of GFP
+ cells in the cortices of JOE
plp/gfp mice. This would be
consistent with Paez et al. (2009b), who found increased rates
of migration in JOE OPCs compared with controls.
In summary, the present paper indicates that increased levels
of golli delays myelination, probably due to significant cell
death of OLs particularly in white matter tracts such as the CC.
These findings are consistent with in vitro studies that indicate
that golli acts by influencing Ca
2+ influx into OPCs/OLs through
store-operated Ca
2+ channels and voltage-gated Ca
2+ channels.
The results provide in vivo evidence for a significant role of the
golli proteins in the regulation and maturation of OLs and
normal myelination. The JOE mouse also provides an unique
model to examine the longer-term effects of hypomyelination
imposed during a critical period of brain development during
which neural networks are being established, axonal sprouting
and synaptic connections are being made and neuronal–glial
relationships are being established.
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